Skip to main content
. 2018 Oct 5;14:2563–2577. doi: 10.2147/NDT.S159704

Figure 1.

Figure 1

Plasma concentration at trough (mean ± SE)–time profile during and following 12-weeks of treatment with cariprazine 6 mg/day.

Notes: Reproduced from the product label.10 DDCAR is the predominant circulating moiety, representing about 70% of the total exposure. When treatment is discontinued, DDCAR concentrations persist longer than for cariprazine or DCAR.

Abbreviations: CAR, cariprazine; DDCAR, didesmethyl-cariprazine; total CAR, summed concentration of cariprazine, DCAR, and DDCAR.